Phase I/Ib study of inavolisib (Inavo) + bevacizumab (Bev) or cetuximab (Cetux) for PIK3CA -mutated (Mut) metastatic colorectal cancer (Mcrc)
Fakih, M., Chen, E. X., Lee, K.-W., Bekaii-Saab, T. S., Lonardi, S., Gong, J., Elez, E., Lau, J., Breton, V., … Read More
